Literature DB >> 9327018

Cilia from a cystic fibrosis patient react to the ciliotoxic Pseudomonas aeruginosa II lectin in a similar manner to normal control cilia--a case report.

E C Adam1, D U Schumacher, U Schumacher.   

Abstract

The ciliary beat frequency measurements taken from a nasal polyp from a cystic fibrosis patient were similar to that of the control nasal polyps. The addition of a ciliotoxic lectin produced by Pseudomonas aeruginosa stopped the beating of the cilia as in the controls. This reaction could be blocked by the pre-incubation of the lectin with its inhibitor fucose. As in the control, the addition of fucose after the cilia had slowed resulted in a return to normal ciliary beating within 24 hours. This shows that the delta F508 CF mutation observed in this patient does not affect ciliary beating and suggests that treatment with fucose in the early stages of a Pseudomonas aeruginosa infection could be advantageous for cystic fibrosis patients.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9327018     DOI: 10.1017/s0022215100138551

Source DB:  PubMed          Journal:  J Laryngol Otol        ISSN: 0022-2151            Impact factor:   1.469


  5 in total

1.  The Pseudomonas aeruginosa lectins PA-IL and PA-IIL are controlled by quorum sensing and by RpoS.

Authors:  K Winzer; C Falconer; N C Garber; S P Diggle; M Camara; P Williams
Journal:  J Bacteriol       Date:  2000-11       Impact factor: 3.490

2.  Glycosylation is required for outer membrane localization of the lectin LecB in Pseudomonas aeruginosa.

Authors:  Kai-Malte Bartels; Horst Funken; Andreas Knapp; Melanie Brocker; Michael Bott; Susanne Wilhelm; Karl-Erich Jaeger; Frank Rosenau
Journal:  J Bacteriol       Date:  2011-01-07       Impact factor: 3.490

3.  Specific association of lectin LecB with the surface of Pseudomonas aeruginosa: role of outer membrane protein OprF.

Authors:  Horst Funken; Kai-Malte Bartels; Susanne Wilhelm; Melanie Brocker; Michael Bott; Manjeet Bains; Robert E W Hancock; Frank Rosenau; Karl-Erich Jaeger
Journal:  PLoS One       Date:  2012-10-08       Impact factor: 3.240

4.  Pseudomonas Aeruginosa Lectins As Targets for Novel Antibacterials.

Authors:  A V Grishin; M S Krivozubov; A S Karyagina; A L Gintsburg
Journal:  Acta Naturae       Date:  2015 Apr-Jun       Impact factor: 1.845

5.  Inhalation with fucose and galactose for treatment of Pseudomonas aeruginosa in cystic fibrosis patients.

Authors:  Hans-Peter Hauber; Maria Schulz; Almuth Pforte; Dietrich Mack; Peter Zabel; Udo Schumacher
Journal:  Int J Med Sci       Date:  2008-11-17       Impact factor: 3.738

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.